The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Altimmune, Inc(NASDAQ:ALT) 
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID...
Website: http://www.altimmune.com
Founded: 1997
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology
Altimmune Days Payable Outstanding ttm (DPO)
Altimmune Days Receivable Outstanding ttm (DSO)
Altimmune Days Inventory Outstanding ttm (DIO)
Altimmune Op Cashflow Per Share ttm
Altimmune Free Cashflow Per Share ttm
Altimmune Cash Per Share ttm
Altimmune P/S ratio ttm
Altimmune (GAAP) P/E ratio ttm
Altimmune P/B ratio ttm
No extra charts and metrics for this ticker.